Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remicade in Bipolar Depression
NCT02363738Phase 2Completed
- Sponsor
- University Health Network
- Start
- Sep 2015
- Primary completion
- Apr 2017
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of infliximab in bipolar disorder (BD), sponsored by University Health Network. Started Sep 2015; status: completed.
02
Drugs
infliximab
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02363738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02363738.